Live Analyst Rating Changes 34764 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Puneet Souda
LP

Puneet Souda

Leerink Partners
Wall Street Analyst
★★★★★
#78
on 13Foresight · ranked by our own returns
85%
Success Rate
+46.0%
Average Return
33 of 39 calls profitable · +97.7% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 85% of Puneet Souda's ratings turned a profit when each position was held for 1 year — averaging +46.0% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

17 Buy 6 Hold 0 Sell
Puneet's Stock Coverage 32 ratings · 2026-09-26
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
TWST
Twist Bioscience
 Sep 17, 2026 BUY Strong Buy
-50.2% avg upside
15 analysts
$160.00
12.43% Downside
 +17.5% ·
SVRN
OceanPal Inc
 Sep 17, 2026 BUY Strong Buy
6 analysts
 — +233.0% ·
NTRA
Natera
 Aug 07, 2026 BUY Strong Buy
-21.9% avg upside
28 analysts
$330.00
20.04% Downside
 +28.1% ·
TXG
10x Genomics
 Jul 17, 2026 HOLD Buy
-47.2% avg upside
18 analysts
$40.00
53.25% Downside
 +96.0% ·
RVTY
Revvity
 Jul 17, 2026 BUY Buy
-23.6% avg upside
23 analysts
 — +36.8% ·
ILMN
Illumina
 Jul 17, 2026 BUY Buy
-33.9% avg upside
31 analysts
$210.00
22.19% Downside
 +44.7% ·
TECH
Bio-Techne
 Jun 25, 2026 HOLD Buy
+14.9% avg upside
21 analysts
$73.00
0.62% Upside
 +2.7% ·
GH
Guardant Health
 Jun 02, 2026 BUY Strong Buy
-5.3% avg upside
32 analysts
 — +36.2% ·
ALMR
Alamar Biosciences, Inc.
 May 12, 2026 BUY Strong Buy
+1.6% avg upside
5 analysts
$35.00
6.74% Upside
 +51.7% ·
NEO
NeoGenomics
 Apr 29, 2026 BUY Buy
-8.0% avg upside
18 analysts
$25.00
29.42% Upside
 +104.9% ·
TMO
Thermo Fisher
 Oct 23, 2025 BUY Strong Buy
-8.8% avg upside
40 analysts
$580.00
14.04% Downside
 +18.2% ·
DHR
Danaher
 Oct 22, 2025 BUY Strong Buy
-5.4% avg upside
47 analysts
$235.00
4.69% Upside
 +3.2% ·
RGEN
Repligen
 Sep 11, 2025 BUY Strong Buy
-9.3% avg upside
25 analysts
$200.00
5.51% Upside
 +38.2% ·
QTRX
Quanterix
 Sep 10, 2025 HOLD Buy
+488.6% avg upside
8 analysts
$6.00
83.51% Upside
 -42.3% ·
BRKR
Bruker
 Sep 07, 2025 BUY Buy
-10.2% avg upside
22 analysts
 — +90.9% ·
A
Agilent
 Sep 01, 2025 BUY Strong Buy
-8.4% avg upside
34 analysts
$140.00
19.03% Downside
 +20.7% ·
VCYT
Veracyte
 Aug 07, 2025 BUY Strong Buy
+13.9% avg upside
19 analysts
$45.00
0.95% Downside
 +70.6% ·
OABI
OmniAb
 Aug 07, 2025 BUY Strong Buy
+76.3% avg upside
10 analysts
$10.00
116.98% Upside
 +63.8% ·
MASS
908 Devices
 Aug 06, 2025 BUY Strong Buy
+9.2% avg upside
5 analysts
$12.00
4.83% Upside
 +27.0% ·
CYRX
CryoPort
 Aug 06, 2025 BUY Strong Buy
-6.2% avg upside
15 analysts
$16.00
8.13% Downside
 +68.1% ·
MYGN
Myriad Genetics
 Aug 06, 2025 HOLD Hold
+291.5% avg upside
24 analysts
$9.00
115.77% Upside
 -43.9% ·
WAT
Waters
 Aug 05, 2025 BUY Strong Buy
-7.7% avg upside
31 analysts
$340.00
21.48% Downside
 +42.2% ·
CSTL
Castle Biosciences
 Aug 05, 2025 BUY Strong Buy
+16.6% avg upside
9 analysts
$35.00
2.27% Downside
 +49.4% ·
LINK
Interlink Electronics
 Jul 29, 2025 BUY Strong Buy
+80.2% avg upside
16 analysts
 — -11.8% ·
HHS
Harte-Hanks
 Jun 01, 2025 BUY Strong Buy
2 analysts
 — -42.4% ·
ABCL
AbCellera Biologics
 May 09, 2025 BUY Strong Buy
+25.7% avg upside
16 analysts
$5.00
60.65% Downside
 +158.1% ·
SNDA
Sonida Senior Living
 May 07, 2024 BUY Buy
+123.5% avg upside
14 analysts
 — -26.6% ·
AB
AllianceBernstein
 Dec 19, 2023 BUY Buy
+2.8% avg upside
8 analysts
 — +18.3% ·
DMRA
Damora Therapeutics
 Apr 29, 2022 BUY Strong Buy
+46.9% avg upside
20 analysts
$16.00
22.66% Downside
 +4.8% ·
TTOO
T2 Biosystems
 Aug 24, 2021 BUY Buy
+1421150.0% avg upside
10 analysts
$3.00
599899.90% Upside
 · ·
HTGMQ
HTG Molecular Diagnostics
 Aug 24, 2021 BUY Strong Buy
+733333233.4% avg upside
6 analysts
$10.00
999999900.05% Upside
 · ·
BAX
Baxter International
 Oct 20, 2014 BUY Buy
+43.0% avg upside
23 analysts
$80.00
242.38% Upside
 -4.8% ·
🔒 27 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Puneet Souda — Frequently Asked Questions
How accurate are Puneet Souda's stock ratings?
Based on the calls 13Foresight could measure, about 85% of Puneet's ratings were profitable over a one-year hold, with an average return of +41.2% per rating, or +92.9% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Puneet ranked on 13Foresight?
Puneet Souda is currently ranked #78 with a 5-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Puneet cover?
Puneet most recently has ratings on TWST, SVRN, NTRA, TXG, RVTY, ILMN, TECH, GH, ALMR, NEO, TMO, DHR and 20 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.